You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
CureVac
since
auto-detected in 50 stories
8 months ago
Here are the stocks making headlines in Thursday's trading.
Covid-19 vaccine-maker BioNTech to acquire former rival CureVac ○
Both German companies have continued mRNA programs on so-called cancer vaccines.
page 1 of 1